Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Syndax Pharma (SNDX)

Syndax Pharma (SNDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 903,994
  • Shares Outstanding, K 48,628
  • Annual Sales, $ 1,520 K
  • Annual Income, $ -73,160 K
  • 60-Month Beta 1.51
  • Price/Sales 592.70
  • Price/Cash Flow N/A
  • Price/Book 4.16
Trade SNDX with:

Options Overview Details

View History
  • Implied Volatility 114.88%
  • Historical Volatility 45.17%
  • IV Percentile 48%
  • IV Rank 37.85%
  • IV High 221.12% on 12/01/20
  • IV Low 50.18% on 06/23/21
  • Put/Call Vol Ratio 0.04
  • Today's Volume 114
  • Volume Avg (30-Day) 127
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 705
  • Open Int (30-Day) 507

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.62
  • Number of Estimates 3
  • High Estimate -0.58
  • Low Estimate -0.65
  • Prior Year -0.46
  • Growth Rate Est. (year over year) -34.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.44 +13.08%
on 10/05/21
20.32 -8.51%
on 09/17/21
-0.77 (-3.98%)
since 09/15/21
3-Month
13.58 +36.89%
on 08/05/21
20.32 -8.51%
on 09/17/21
+3.19 (+20.71%)
since 07/15/21
52-Week
13.02 +42.78%
on 04/21/21
27.85 -33.25%
on 12/07/20
+1.94 (+11.65%)
since 10/15/20

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Syndax Pharmaceuticals, Inc. is a biopharmaceutical company which focused on the development and commercialization of entinostat, an epigenetic therapy for treatment-resistant cancers. The Company's product pipeline includes ENCORE 601, ENCORE 602, J1353, NCI-7870, NCI-9844, E2112, NCI-8871 and NCI-9253...

See More

Key Turning Points

3rd Resistance Point 19.66
2nd Resistance Point 19.35
1st Resistance Point 18.97
Last Price 18.59
1st Support Level 18.27
2nd Support Level 17.96
3rd Support Level 17.58

See More

52-Week High 27.85
Fibonacci 61.8% 22.18
Fibonacci 50% 20.44
Fibonacci 38.2% 18.69
Last Price 18.59
52-Week Low 13.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar